Hemab Therapeutics indicating open at $21, IPO priced at $18

May 1, 2026 9:55 AM EDT Send to a Friend

(Updated - May 1, 2026 9:57 AM ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Hemab Therapeutics indicating open at $21, IPO priced at $18

Member Login

Free News Feed